The question remains: what will it take to prove that any protection device is having a meaningful impact on stroke risk?

A device designed to capture more TAVR procedural debris proves noninferior to an existing device in a large trial, but the ...

In the first head-to-head comparison of two devices intended to protect against stroke in patients undergoing transcatheter ...

SILVER SPRING, MD — Unanimously disappointed with the end point used to determine clinical benefit, advisors to the US Food and Drug Administration (FDA) agreed the Sentinel Cerebral Protection System ...